Clinical Trials
All Clinical Trials - Page 39 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01846728N/ACompleted
Effects of Estrogen Deficiency on Energy Expenditure
Gonadorelin
- NCT02440802N/AUnknown
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer
Gonadorelin
- NCT01847313Phase 3Completed
The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney Disease
Liraglutide
- NCT01845259Phase 2Unknown
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
Liraglutide
- NCT01800968Phase 2Completed
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Liraglutide
- NCT01744236Phase 4Completed
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Liraglutide
- NCT01832532Phase 1/Phase 2Completed
A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
Liraglutide
- NCT01787916Phase 4Completed
52 Week Trial of Liraglutide in Type 1 Diabetes
Liraglutide
- NCT01843127Phase 1Completed
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
Exenatide
- NCT01809691Phase 3Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Gonadorelin
- NCT01815138Phase 4Completed
Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS
Gonadorelin
- NCT01816789Phase 4Terminated
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
Gonadorelin
- NCT02092896Phase 3Completed
Liraglutide as add-on to Insulin in Type 1 Diabetes
Liraglutide
- NCT01785043Phase 4Completed
Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
Liraglutide
- NCT02403284Phase 4Completed
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
Liraglutide
- NCT01455857Phase 3Completed
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
Exenatide
- NCT01818648Phase 4Withdrawn
Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Exenatide
- NCT01455896Phase 3Completed
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
Exenatide
- NCT01791465Phase 4Terminated
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults
Exenatide
- NCT01725126Phase 2Completed
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Liraglutide
- NCT01786265Phase 2Active Not Recruiting
Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
Gonadorelin
- NCT01579695N/ATerminated
Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
Tesamorelin
- NCT01833078Phase 2Completed
Ghrelin Repeated Dose Study
Ghrp-6
- NCT01786915Phase 1Completed
Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
Elamipretide
- NCT01798836Phase 2/Phase 3Terminated
Oestradiol Pre-treatment in an Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol in Poor Responders Undergoing IVF
Gonadorelin
- NCT01856790EARLY_Phase 1Completed
Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
Liraglutide
- NCT01733758Phase 3Completed
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
Liraglutide
- NCT02201550N/ACompleted
Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
Liraglutide
- NCT01790308Phase 4Unknown
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
Liraglutide
- NCT01789086Phase 1Completed
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
Liraglutide
- NCT01455922Phase 3Withdrawn
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
Exenatide
- NCT01455883Phase 3Withdrawn
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
Exenatide
- NCT02349802Phase 1Completed
Autoinjector Device Assessment Study
Exenatide
- NCT01652729Phase 3Completed
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT01455909Phase 3Withdrawn
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
Exenatide
- NCT01794429Phase 3Completed
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
Exenatide
- NCT03297879Phase 4Completed
Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
Exenatide
- NCT01715129Phase 3Completed
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
Gonadorelin
- NCT01744366Phase 3Completed
One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population
Gonadorelin
- NCT02113332Phase 2Completed
Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
Liraglutide
- NCT01755416Phase 2Completed
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
Liraglutide
- NCT01755572Phase 4Completed
Blood Pressure Outcomes With Liraglutide Therapy
Liraglutide
- NCT01769378Phase 3Completed
Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
Dulaglutide
- NCT01652716Phase 3Completed
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Exenatide
- NCT01767090Phase 2Completed
A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
Gonadorelin
- NCT01766245Phase 1Completed
A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes
Semaglutide
- NCT01746849Phase 2Active Not Recruiting
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Ghrp-6
- NCT01755858Phase 1/Phase 2Terminated
Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery
Elamipretide
- NCT01780220Phase 1/Phase 2Completed
Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery
Gonadorelin
- NCT01753362Phase 3Completed
Liraglutide In Overweight Patients With Type 1 Diabetes
Liraglutide